Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-09-25 | Karen Drexler is a newly-nominated candidate for director. Ms. Drexler is chief executive officer and a board member of Sandstone Diagnostics, Inc., a private company developing instruments and consumables for point-of-care medical testing. She has been on its board since 2014, and became CEO in 2016. Ms. Drexler was the president and chief executive officer of Amira Medical Inc., a private company focused on minimally invasive glucose monitoring technology, from 1996 until it was sold to Roche Holding AG in 2001. |
| 2018-10-03 | Karen Drexler has served as our director since November 2017. She is a member of our compensation committee. ... Ms. Drexler's executive and board experience in the medical diagnostics and medical device industries, particularly her experience in technology and data security, and out-of-hospital care models, led our board to conclude she should serve as a director. |
| 2019-10-08 | Karen Drexler has served as ResMed’s director since November 2017, and is a member of its compensation committee. ... Ms. Drexler’s executive and board experience in the medical diagnostics and medical device industries, particularly her experience in technology and data security, and out-of-hospital care models, led our board to conclude she should serve as a director. |
| 2020-10-06 | Karen Drexler has served as ResMed’s director since November 2017 and is a member of its compensation committee. ... Ms. Drexler’s executive and board experience in the medical diagnostics and medical device industries, particularly her experience in digital health, technology and data security, and out-of-hospital care models, led our board to conclude she should serve as a director. |
| 2021-10-06 | Karen Drexler has served as ResMed’s director since November 2017, and is a member of our compensation and nominating and governance committees. Ms. Drexler is a serial entrepreneur with expertise in the fields of digital health, medical devices, and diagnostics. ... Ms. Drexler graduated magna cum laude with a B.S.E. in chemical engineering from Princeton University, and earned an M.B.A. with honors from the Stanford University Graduate School of Business. ... Ms. Drexler’s executive and board experience in the medical diagnostics and medical device industries, particularly her experience in digital health, technology, and data security, and out-of-hospital care models, led our board to conclude she should serve as a director. |
| 2022-10-05 | Karen Drexler has served as a ResMed director since November 2017, and is a member of our compensation and nominating and governance committees. ... Fiscal year 2022 director compensation table ... Karen Drexler $70,000 fees earned in cash, $125,023 option awards, $124,987 restricted stock units, total $320,011. |
| 2023-10-05 | Karen Drexler has served as a ResMed director since November 2017, and is a member of our compensation and nominating and governance committees. ... Ms. Drexler’s executive and board experience in the medical diagnostics and medical device industries, particularly her experience in digital health, technology, and data security, and out-of-hospital care models, led our board to conclude she should serve as a director. |
| 2024-10-03 | Karen Drexler | 64 Independent Former Board Member and Chief Executive Officer of Sandstone Diagnostics, Inc. Director since: 2017 Committees: Compensation (Chair), Nominating and Governance |
Data sourced from SEC filings. Last updated: 2026-02-03